Capillary electrophoresis coupled to electrospray ionization tandem mass spectrometry (CE-MS/MS) for ultra-sensitive proteomic analysis of limited sample
Ontology highlight
ABSTRACT: In this work, we developed an ultra-sensitive CE-MS/MS method for bottom-up proteomics analysis of limited samples, down to sub-nanogram levels of total protein. Analysis of 880 pg and 88 pg of HeLa protein digest standard by CE-MS/MS yielded ~1,100±46 and ~160±59 proteins, respectively, demonstrating higher protein and peptide identifications than the current state-of-the-art CE-MS/MS-based proteomic analyses with similar amounts of sample. To demonstrate potential applications of our ultra-sensitive CE-MS/MS method for analysis of limited biological samples, we digested 500 and 1,000 HeLa cells using a miniaturized in-solution digestion workflow. From 1-, 5-, and 10-cell equivalents injected from the resulted digests, we identified 744±127, 1,139±24, and 1,271±6 proteins and 3,353±719, 5,709±513, and 8,527±114 peptide groups, respectively. Furthermore, we performed a comparative assessment of CE-MS/MS and two reversed-phased nano-liquid chromatography (RP-nLC-MS/MS) methods (monolithic and packed columns) for the analysis of a ~10 ng HeLa protein digest standard. Our results demonstrate complementarity in the protein-, and especially peptide-level identifications of the evaluated CE-MS- and RP-nLC-MS-based methods. The techniques were further assessed to detect post-translational modifications and highlight the strengths of the CE-MS/MS approach in identifying potentially important and biologically relevant modified peptides. With a migration window of ~60 min, CE-MS/MS identified ~2,000±53 proteins on average from a single injection of ~8.8 ng HeLa protein digest standard. Additionally, an average of 232±10 phosphopeptides and 377±14 N-terminal acetylated peptides were identified in CE-MS/MS analyses at this sample amount corresponding to 2- and 1.5-fold more identifications for each respective modification found by nLC-MS/MS methods.
INSTRUMENT(S): Orbitrap Fusion Lumos
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Epithelial Cell, Cell Culture, Hela Cell
DISEASE(S): Cervix Carcinoma
SUBMITTER: Kendall Johnson
LAB HEAD: Alexander R. Ivanov
PROVIDER: PXD027226 | Pride | 2022-02-17
REPOSITORIES: Pride
ACCESS DATA